Toripalimab in the Neoadjuvant Treatment of BRAF V600 Wild Type Melanoma

Clinical trial NCT04248387 · UNKNOWN

Trial details

NCT number: NCT04248387
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma Stage IIIB-IV

Start date: 2019-06-17
Primary completion: 2022-04-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.